Surmodics, Inc. (SRDX) delivered adjusted loss per share of 4 cents in the first quarter of fiscal 2025 against the year-ago quarter’s breakeven level. The metric was narrower than the Zacks Consensus Estimate of a loss of 8 cents per share.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.GAAP loss per share for the quarter was 26 cents, wider than the year-earlier loss of 6 cents per share.Surmodics’ Revenues in DetailSurmodics registered revenues of $29.9 million in the fiscal first ...